Related Experiment Videos
Transjugular intrahepatic portosystemic shunts: an update
Barbara Rosado1, Patrick S Kamath
1Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Summary
Transjugular intrahepatic portosystemic shunts (TIPS) effectively manage portal hypertension complications like variceal bleeding and ascites. Regular monitoring is crucial to prevent shunt dysfunction and ensure long-term patient success.
Area of Science:
- Interventional Radiology
- Hepatology
- Gastroenterology
Background:
- Portal hypertension complications, including variceal bleeding and refractory ascites, pose significant clinical challenges.
- Pharmacologic and endoscopic therapies may fail, necessitating alternative treatment strategies.
Purpose of the Study:
- To review the indications, limitations, and management of transjugular intrahepatic portosystemic shunts (TIPS).
- To highlight the importance of shunt surveillance and prognostic factors for TIPS success.
Main Methods:
- Review of current literature and clinical practice regarding TIPS procedures.
- Analysis of patient selection criteria, procedural outcomes, and complication management.
Main Results:
- TIPS is effective for acute variceal bleeding, preventing rebleeding, and managing refractory ascites in select patients.
- Indications include Budd-Chiari syndrome, portal hypertensive gastropathy, hepatic hydrothorax, and hepatorenal syndrome.
- Shunt dysfunction and hepatic encephalopathy are major limiting factors; shunt stenosis necessitates surveillance.
Conclusions:
- TIPS is a valuable treatment for specific complications of portal hypertension when other therapies fail.
- Careful patient selection, proper stent placement, and diligent post-procedure surveillance are essential for optimal outcomes.
- The MELD score aids in predicting survival and patient counseling.